Glenmark Pharma launches drug for diabetic patients with comorbidities

Glenmark Pharma launches drug for diabetic patients with comorbidities The Mumbai-based drug maker said it has become the first company to launch Teneligliptin (20mg) Dapagliflozin (5mg/10mg) fixed-dose combination for the treatment of adult patients with type 2 diabetes.

from Moneycontrol Business News https://ift.tt/4GizkQb
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...